Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
Conditions: Leiomyosarcoma; Myxofibrosarcoma; Resectable Dedifferentiated Liposarcoma; Resectable Soft Tissue Sarcoma; Resectable Undifferentiated Pleomorphic Sarcoma; Soft Tissue Fibrosarcoma; Spindle Cell Sarcoma; Stage I Retroperitoneal Sarcoma American Joint Committee on Cancer (AJCC) v8; Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IA Retroperitoneal Sarcoma AJCC v8; Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8;...
Source: ClinicalTrials.gov - June 9, 2020 Category: Research Source Type: clinical trials
Preoperative Hypofractionated Radiotherapy With Hyperthermia in Primary Marginally Unresectable or Marginally Resectable Soft Tissue Sarcomas
Conditions: Sarcoma; Alveolar Soft Part Sarcoma; Clear Cell Sarcoma; Malignant Peripheral Nerve Sheath Tumors; Myxoid Liposarcoma; Liposarcoma, Dedifferentiated; Synovial Sarcoma; Leiomyosarcoma; Undifferentiated Pleomorphic Sarcoma; Fibrosarcoma; Pleomorphic Rha bdomyosarcoma Interventions: Radiation: Hypofractionated radiotherapy; Other: Hyperthermia Sponsor: Maria Sklodowska-Curie Institute - Oncology Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2019 Category: Research Source Type: clinical trials
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Conditions: Soft Tissue Sarcoma; Clear Cell Sarcoma; Epithelioid Sarcoma; Perivascular Epithelioid Cell Neoplasms; Desmoplastic Small Round Cell Tumor; Solitary Fibrous Tumors; Alveolar Soft Part Sarcoma; Epithelioid Hemangioendothelioma; Low Grade Fibromyxoid Sa rcoma; Sclerosing Epithelioid Fibrosarcoma Intervention: Other: Patient with Soft Tissue Sarcoma Sponsor: Institut Claudius Regaud N...
Source: ClinicalTrials.gov - May 30, 2019 Category: Research Source Type: clinical trials
A Study of Oral LOXO-292 in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors
Conditions: Medullary Thyroid Cancer; Infantile Myofibromatosis; Infantile Fibrosarcoma; Papillary Thyroid Cancer; Soft Tissue Sarcoma Intervention: Drug: LOXO-292 Sponsor: Loxo Oncology, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2019 Category: Research Source Type: clinical trials
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
Conditions: Blasts 5 Percent or More of Bone Marrow Nucleated Cells; Central Nervous System Neoplasm; ETV6 Gene Rearrangement; Infantile Fibrosarcoma; NTRK1 Fusion Positive; NTRK1 Gene Rearrangement; NTRK2 Fusion Positive; NTRK2 Gene Rearrangement; NTRK3 Fusion Positi ve; NTRK3 Gene Rearrangement; Recurrent Acute Leukemia; Refractory Acute Leukemia; Solid Neoplasm Intervention: Drug: Larotrectinib Sponsors: &...
Source: ClinicalTrials.gov - February 8, 2019 Category: Research Source Type: clinical trials